|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.44/-0.08
|
企業價值
2.06B
|
資產負債 |
每股賬面淨值
4.17
|
現金流量 |
現金流量率
--
|
損益表 |
收益
627.12M
|
每股收益
0.81
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/06 21:35 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol. |